(5-BROMO-4-CHLORO-3-INDOXYL-ALPHA-D-XYLOPYRANOSIDE)

Information Error Report

Your Email:

Browse by Nationality 5-BROMO-4-CHLORO-3-INDOXYL-ALPHA-D-XYLOPYRANOSIDE Suppliers

China suppliers

Switzerland(2)	United States(2)	Member(6)	All(6)
United Kingdom(2)

5-BROMO-4-CHLORO-3-INDOXYL-ALPHA-D-XYLOPYRANOSIDE Recommend Suppliers

Recommend You Select Member Companies.

Company Name:	BOC Sciences    Recommend    Complaint
Tel:	+1-631-485-4226
Email:	inquiry@bocsci.com
Nationality:	United States
Products Intro:	Product Name:5-Bromo-4-chloro-3-indolyl a-D-xylopyranoside Remarks:BOC Sciences also provides custom synthesis services for 5-Bromo-4-chloro-3-indolyl a-D-xylopyranoside.
CB Index:	58
WebSite:	www.bocsci.com/
Related Information:	Sales Network   Catalog(19553)   User Evaluation

Company Name:	BIOSYNTH AG    Recommend    Complaint
Tel:	+41 (0)71 858 20 20
Email:	welcome@biosynth.ch
Nationality:	Switzerland
Products Intro:	Product Name:5-Bromo-4-chloro-3-indoxyl-alpha-D-xylopyranoside Package:2.5g
CB Index:	60
WebSite:	www.biosynth.com
Related Information:	Sales Network   Catalog(1308)   User Evaluation

Company Name:	Carbosynth Limited    Recommend    Complaint
Tel:	+44 (0)1635 247150
Email:	sales@carbosynth.com
Nationality:	United Kingdom
Products Intro:	Product Name:5-Bromo-4-chloro-3-indolyl a-D-xylopyranoside Package:$100.00/1mg;$380.00/2mg;$900.00/5mg;$1500.00/10mg;$2500.00/25mg; Remarks:EB08271
CB Index:	61
WebSite:	www.carbosynth.com
Related Information:	Sales Network   Catalog(6585)   User Evaluation(2)

Company Name:	Chem-Impex International, Inc.    Recommend    Complaint
Tel:	800 869-9290 US and Canada only
Email:
Nationality:	United States
Products Intro:
CB Index:	64
WebSite:	www.chemimpex.com
Related Information:	Sales Network   Catalog(6740)   User Evaluation(4)

Company Name:	Biosynth AG    Recommend    Complaint
Tel:	+41 71 858 20 20
Email:	welcome@biosynth.ch
Nationality:	Switzerland
Products Intro:
CB Index:	72
WebSite:	www.biosynth.com
Related Information:	Sales Network   Catalog(3324)   User Evaluation

1 2